Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GlobalData
CRO
Midstage cancer tests 'heavily impacted' by COVID-19 disruptions
A new survey of biopharma execs has shown phase 2 oncology trials are the most disrupted.
Ben Adams
Jun 9, 2021 7:05am
Trials ramping back up, but slow takeup of places remains
May 12, 2021 7:35am
More trials to get back on track in U.S./U.K. amid vax uptake
Mar 29, 2021 9:37am
Make rare disease trials virtual to boost uptake: report
Mar 11, 2021 3:29am
New COVID-19 mutations putting a strain on trial resumptions
Feb 16, 2021 7:25am
Trials 'unable to bounce back' after COVID-19 chaos: report
Sep 17, 2020 7:25am
